Cushing's Syndrome Completed Phase 2 Trials for Pasireotide (DB06663)

Also known as: Cushing Syndrome / Cushing’s syndrome / Cushings syndrome / Syndrome Cushing's

IndicationStatusPhase
DBCOND0028130 (Cushing's Syndrome)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00088608A Study to Assess SOM230 in Patients With Pituitary Cushing's DiseaseTreatment